Citius Oncology, Inc.
The momentum for this stock is not very good. Citius Oncology, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Citius Oncology, Inc. .
Log in to see more information.
News
Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
PR Newswire Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference Citius Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment...\n more…
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncolo
PR Newswire Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce LYMPHIR (Denileukin Diftitox-cxdl) Added to National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology...\n more…